As we observed an increase in IL-36α protein expression in the serum of paediatric IBD patients, alongside the potential for this cytokine to be acting on CD3+ T cells in the mucosa, we next sought to investigate the specific effect of IL-36 on T cell responses in the pathogenesis of colitis. This evidence concerns the gene IL36A and inflammatory bowel disease.